Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.
Chen Y, Du CY, Shen S, Zhang W, Shan Y, Lyu A, Wu J, Shang C, Luo X, Wei J, Xiao H, Qiu J, Hua Y, Wang S, Wang T, Dai S, Zhang S, Xie B, Wu Y, Hao C.
Chen Y, et al. Among authors: shen s.
Clin Cancer Res. 2024 Apr 30. doi: 10.1158/1078-0432.CCR-24-0006. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38687583